These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 11280541
1. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Am J Gastroenterol; 2001 Mar; 96(3):722-9. PubMed ID: 11280541 [Abstract] [Full Text] [Related]
2. Infliximab for Crohn's disease in clinical practice: the experience of a single center in romania. Gheorghe L, Gheorghe C, Badea M, Vădan R, Pârvulescu I, Toader C, Tugui L, Papuc O, Ionescu R, Preda C, Călin I, Diculescu M. Rom J Gastroenterol; 2003 Mar; 12(1):7-13. PubMed ID: 12673373 [Abstract] [Full Text] [Related]
3. Infliximab treatment and prognostic factors for response in patients with Crohn's disease. Mendoza JL, García-Paredes J, Cruz Santamaria DM, Lana R, Ramírez Fernández E, Rodríguez Asteaga E, Díaz-Rubio M. Rev Esp Enferm Dig; 2002 May; 94(5):269-79. PubMed ID: 12474335 [Abstract] [Full Text] [Related]
4. Infliximab in the surgical management of complex fistulating anal Crohn's disease. Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D. Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356 [Abstract] [Full Text] [Related]
5. Clinical outcome of Crohn's disease treated with infliximab. Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tözün N, Hamzaoglu HO, Duman D, Ulker A, Parlak E, Palabiyikoglu M, Dökmeci A. Hepatogastroenterology; 2003 Mar; 50(52):952-6. PubMed ID: 12845957 [Abstract] [Full Text] [Related]
6. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab. Bouguen G, Trouilloud I, Siproudhis L, Oussalah A, Bigard MA, Bretagne JF, Peyrin-Biroulet L. Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709 [Abstract] [Full Text] [Related]
7. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Sands BE, Blank MA, Diamond RH, Barrett JP, Van Deventer SJ. Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1127-36. PubMed ID: 16611273 [Abstract] [Full Text] [Related]
8. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q, Hogezand RA, Lamers CB, Verspaget HW. Aliment Pharmacol Ther; 2004 Sep 01; 20(5):585-92. PubMed ID: 15339330 [Abstract] [Full Text] [Related]
9. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F. Scand J Gastroenterol; 2006 Sep 01; 41(9):1064-72. PubMed ID: 16938720 [Abstract] [Full Text] [Related]
10. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Dis Colon Rectum; 2006 Dec 01; 49(12):1837-41. PubMed ID: 17041753 [Abstract] [Full Text] [Related]
11. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease. Hlavaty T, Pierik M, Henckaerts L, Ferrante M, Joossens S, van Schuerbeek N, Noman M, Rutgeerts P, Vermeire S. Aliment Pharmacol Ther; 2005 Oct 01; 22(7):613-26. PubMed ID: 16181301 [Abstract] [Full Text] [Related]
12. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P, Peppercorn MA. Am J Gastroenterol; 2000 Dec 01; 95(12):3490-7. PubMed ID: 11151882 [Abstract] [Full Text] [Related]
13. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Sandborn WJ, Hanauer SB. Am J Gastroenterol; 2002 Dec 01; 97(12):2962-72. PubMed ID: 12492177 [Abstract] [Full Text] [Related]
14. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S. Dig Liver Dis; 2004 May 01; 36(5):342-7. PubMed ID: 15191204 [Abstract] [Full Text] [Related]
15. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease. Ochsenkühn T, Göke B, Sackmann M. Am J Gastroenterol; 2002 Aug 01; 97(8):2022-5. PubMed ID: 12190171 [Abstract] [Full Text] [Related]
16. Infliximab in Hispanics: characterization of response to infliximab in an ethnic minority with Crohn's disease. Sánchez JM, Maldonado JC, Torres EA, Rivera C. P R Health Sci J; 2005 Mar 01; 24(1):11-7. PubMed ID: 15895872 [Abstract] [Full Text] [Related]
17. Guidelines for treatment with infliximab for Crohn's disease. Hommes DW, Oldenburg B, van Bodegraven AA, van Hogezand RA, de Jong DJ, Romberg-Camps MJ, van der Woude J, Dijkstra G, Dutch Initiative on Crohn and Colitis (ICC). Neth J Med; 2006 Mar 01; 64(7):219-29. PubMed ID: 16929083 [Abstract] [Full Text] [Related]
18. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Domènech E, Hinojosa J, Nos P, Garcia-Planella E, Cabré E, Bernal I, Gassull MA. Aliment Pharmacol Ther; 2005 Dec 01; 22(11-12):1107-13. PubMed ID: 16305724 [Abstract] [Full Text] [Related]
19. Management of Crohn's disease of the ileoanal pouch with infliximab. Colombel JF, Ricart E, Loftus EV, Tremaine WJ, Young-Fadok T, Dozois EJ, Wolff BG, Devine R, Pemberton JH, Sandborn WJ. Am J Gastroenterol; 2003 Oct 01; 98(10):2239-44. PubMed ID: 14572574 [Abstract] [Full Text] [Related]
20. Prolonged duration of response to infliximab in early but not late pediatric Crohn's disease. Kugathasan S, Werlin SL, Martinez A, Rivera MT, Heikenen JB, Binion DG. Am J Gastroenterol; 2000 Nov 01; 95(11):3189-94. PubMed ID: 11095340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]